{"database": "openregs", "table": "legislation", "rows": [["110-s-3633", 110, "s", 3633, "Transparency in Drug Labeling Act", "Health", "2008-09-26", "2008-09-26", "Read twice and referred to the Committee on Health, Education, Labor, and Pensions.", "Senate", "Sen. Brown, Sherrod [D-OH]", "OH", "D", "B000944", 0, "Transparency in Drug Labeling Act - Amends the Federal Food, Drug, and Cosmetic Act to deem a drug to be misbranded unless the labeling of such drug lists the identity of the country of manufacture of each active ingredient and each inactive ingredient of the drug, listed in descending order based on the percentage of the number of such ingredients in the final dosage form manufactured in such countries.", "2022-02-03T05:09:49Z", null]], "columns": ["bill_id", "congress", "bill_type", "bill_number", "title", "policy_area", "introduced_date", "latest_action_date", "latest_action_text", "origin_chamber", "sponsor_name", "sponsor_state", "sponsor_party", "sponsor_bioguide_id", "cosponsor_count", "summary_text", "update_date", "url"], "primary_keys": ["bill_id"], "primary_key_values": ["110-s-3633"], "units": {}, "query_ms": 0.484930002130568, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}